Stay updated on PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.

Latest updates to the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision marker changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.7.0 was added to the page, signaling the latest version of the study record or site update. This change represents a metadata update rather than modification to the study data or visible content.SummaryDifference21%

- Check55 days agoChange DetectedA new funding source line (2016 U.S. NIH Grant/Contract) is added to the study identifiers, and the page revision is updated to v3.6.6.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now lists Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page's revision metadata.SummaryDifference0.0%

- Check91 days agoChange DetectedRevision: v3.6.4 is now displayed, replacing v3.6.3. This indicates a new version of the page source rather than a change to study details or functionality.SummaryDifference0.0%

Stay in the know with updates to PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001 with Chemo and Immunology Agents in NSCLC Clinical Trial page.